American Journal of Ophthalmology
Volume 133, Issue 2 , Pages 242-248, February 2002

Altered expression of rb and p53 in uveal melanomas following plaque radiotherapy1

  • Milam A Brantley Jr, MD, PhD

      Affiliations

    • Center for Ocular Oncology, Department of Ophthalmology and Visual Sciences and Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri USA
  • ,
  • Lori Worley, BS

      Affiliations

    • Center for Ocular Oncology, Department of Ophthalmology and Visual Sciences and Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri USA
  • ,
  • J.William Harbour, MD

      Affiliations

    • Center for Ocular Oncology, Department of Ophthalmology and Visual Sciences and Division of Molecular Oncology, Washington University School of Medicine, St. Louis, Missouri USA
    • Corresponding Author InformationAddress reprint requests to J. William Harbour, MD, Washington University, Box 8069, 660 S. Euclid Ave., St. Louis, MO 63110 USA

Accepted 9 April 2001.

Abstract 

PURPOSE : To examine the expression of proteins in the Rb and p53 tumor suppressor pathways in uveal melanomas following plaque radiotherapy.

METHODS : Immunohistochemistry and cell culture studies. Immunohistochemistry for Rb, p16, cyclin D1, p53, HDM2, and Bcl-2 was performed on twelve eyes containing posterior uveal melanomas that were enucleated following plaque radiotherapy. Cell culture studies were performed in three cases.

RESULTS : The irradiated eyes were enucleated for radiation complications (five cases), local tumor recurrence (three cases), and other reasons (four cases). On histopathologic examination, all cases showed evidence of tumor cell loss. However, residual tumor cells were present in all cases, including those that were clinically regressed. Residual cells from three of the clinically regressed cases were cultured and demonstrated minimal cell division, marked cell death, and extensive chromosomal damage. Strong p53 staining was observed in six cases (50%) and was significantly associated with recent radiotherapy (P = .04). Abnormal cytoplasmic staining for Rb was observed in four cases (33%).

CONCLUSIONS : Plaque radiotherapy of uveal melanomas induces DNA damage, inhibits cell division, and promotes cell death. These changes may be due, at least in part, to induction of p53, which activates genes involved in both cell cycle arrest and apoptosis. Plaque radiotherapy can also cause alterations in the expression of Rb, but the significance of this finding will require further study.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 
  • 1 The author has no proprietary interest in this study.

 This work was supported by NIH grants K08 EY00382-01 and R01 EY13169-01. Dr. Harbour was supported by a Career Development Award from Research to Prevent Blindness, Inc.

PII: S0002-9394(01)01362-9

American Journal of Ophthalmology
Volume 133, Issue 2 , Pages 242-248, February 2002